Immuneering
IMRX
IMRX
59 hedge funds and large institutions have $12.3M invested in Immuneering in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% less capital invested
Capital invested by funds: $34.3M → $12.3M (-$22M)
Holders
59
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$704K | |
| 3 | +$492K | |
| 4 |
Renaissance Technologies
New York
|
+$447K |
| 5 |
Goldman Sachs
New York
|
+$368K |
Top Sellers
| 1 | -$9.52M | |
| 2 | -$1.08M | |
| 3 | -$736K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$394K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$308K |